4E96

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor PFi-1

Functional Information from PDB Data

site_id	AC1
Number of Residues	10
Details	BINDING SITE FOR RESIDUE 0NS A 201

Chain	Residue
A	TRP81
A	HOH328
A	VAL87
A	ASP96
A	LYS99
A	ASN140
A	ILE146
A	MET149
A	HOH308
A	HOH313

---

site_id	AC2
Number of Residues	2
Details	BINDING SITE FOR RESIDUE NA A 202

Chain	Residue
A	LYS102
A	HOH314

---

site_id	AC3
Number of Residues	3
Details	BINDING SITE FOR RESIDUE DMS A 203

Chain	Residue
A	PRO86
A	LYS112
A	HOH325

---

site_id	AC4
Number of Residues	5
Details	BINDING SITE FOR RESIDUE EDO A 204

Chain	Residue
A	ILE100
A	ILE101
A	LYS102
A	THR103
A	ASN135

---

Functional Information from PROSITE/UniProt

site_id	PS00633
Number of Residues	60
Details	BROMODOMAIN_1 Bromodomain signature. AwpFqqpvDavklnlpDYYkiIktpMdmgtIkkrlenny..Ywnaqeciqdfnt.MftNCyiY

Chain	Residue	Details
A	ALA80-TYR139

---

Functional Information from SwissProt/UniProt

site_id	SWS_FT_FI1
Number of Residues	1
Details	SITE: Acetylated histone binding => ECO:0000269|PubMed:22464331

Chain	Residue	Details
A	ASN140

---

site_id	SWS_FT_FI2
Number of Residues	2
Details	CROSSLNK: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733

Chain	Residue	Details
A	LYS99

---